| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1021641112 |
| P356 | DOI | 10.1007/S10384-015-0417-X |
| P698 | PubMed publication ID | 26498642 |
| P2093 | author name string | Tomohiro Iida | |
| Kanako Itagaki | |||
| Mariko Kano | |||
| Masaaki Saito | |||
| P2860 | cites work | Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor | Q71402232 |
| Reticular pseudodrusen. A risk factor in age-related maculopathy | Q71766689 | ||
| Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap | Q73109816 | ||
| The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes | Q78106430 | ||
| Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation | Q80164793 | ||
| Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP) | Q83358279 | ||
| [Re-treatment guideline of ranibizumab (genetical recombination) in the maintenance phase] | Q85052465 | ||
| Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography | Q87406412 | ||
| Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results | Q24633874 | ||
| Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
| Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. | Q30653873 | ||
| Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. | Q30824036 | ||
| Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization. | Q33717512 | ||
| Geographic atrophy in retinal angiomatous proliferation | Q33819628 | ||
| Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation. | Q33886005 | ||
| Retinal angiomatous proliferation in age-related macular degeneration | Q34408086 | ||
| Ranibizumab versus verteporfin for neovascular age-related macular degeneration. | Q34652928 | ||
| Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization | Q35763708 | ||
| Angiographic results of retinal-retinal anastomosis and retinal-choroidal anastomosis after treatments in eyes with retinal angiomatous proliferation | Q36222187 | ||
| Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation | Q36339520 | ||
| Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation | Q36786477 | ||
| The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials | Q36924781 | ||
| Increased expression of angiogenic growth factors in age-related maculopathy | Q43095714 | ||
| Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation | Q43201348 | ||
| "Treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation. | Q43246127 | ||
| Reticular pseudodrusen are subretinal drusenoid deposits | Q43264954 | ||
| Optical coherence tomography-based ranibizumab monotherapy for retinal angiomatous proliferation in Korean patients | Q43435406 | ||
| Two-year results of combined intravitreal anti-VEGF agents and photodynamic therapy for retinal angiomatous proliferation | Q43437549 | ||
| Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation | Q44490267 | ||
| The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. | Q44975780 | ||
| Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment | Q45209446 | ||
| Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. | Q45974152 | ||
| A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study | Q46045838 | ||
| Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation | Q46275962 | ||
| Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation | Q46414102 | ||
| Recurrent retinal angiomatous proliferation after surgical ablation. | Q46462730 | ||
| Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. | Q46732913 | ||
| Prevalence and genomic association of reticular pseudodrusen in age-related macular degeneration | Q50239730 | ||
| Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. | Q50444746 | ||
| Intravitreal ranibizumab for exudative age-related macular degeneration with good baseline visual acuity. | Q50500200 | ||
| Combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation. | Q50507915 | ||
| Recurrence after surgical ablation for retinal angiomatous proliferation. | Q50697882 | ||
| Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. | Q50701319 | ||
| Clinical characteristics of exudative age-related macular degeneration in Japanese patients. | Q51752922 | ||
| Deep retinal vascular anomalous complexes in advanced age-related macular degeneration. | Q64976394 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 42-50 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Japanese Journal of Ophthalmology | Q15752406 |
| P1476 | title | Two-year results of combined intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation | |
| P478 | volume | 60 |
| Q50585530 | CLINICOPATHOLOGIC CORRELATION OF RETINAL ANGIOMATOUS PROLIFERATION TREATED WITH RANIBIZUMAB. |
| Q37330206 | Nuclear Factor (Erythroid-Derived)-Related Factor 2-Associated Retinal Pigment Epithelial Cell Protection under Blue Light-Induced Oxidative Stress. |
| Q42364456 | Spotlight on reticular pseudodrusen. |
Search more.